Microvessel count predicts metastatic disease and survival in non-small cell lung cancer
- PMID: 7472781
- DOI: 10.1002/path.1711770110
Microvessel count predicts metastatic disease and survival in non-small cell lung cancer
Abstract
The growth of newly formed vessels, or neoangiogenesis, represents an important step in both physiological and pathological situations: in particular, tumour growth and metastasis require angiogenesis. Microvessel count (MC), which represents a measure of tumour angiogenesis, has been associated with metastatic spread in cutaneous, mammary, prostatic, head and neck, and early-stage lung cancer. In this study, the role of tumour angiogenesis as a prognostic indicator was examined in 253 primary non-small lung cancer (NSCLC) patients. Microvessels were counted by highlighting endothelial cells with anti-Factor VIII monoclonal antibody (Mab) in methacarn-fixed tumour samples. In univariat analysis, MC (P< 0.000001), sex (P=0.0036), histotype (P < 0.014), tumour status (P <0.007), and vessel invasion (P < 0.019) were significantly related to hilar and/or mediastinal nodal involvement. However, in the stepwise logistic regression analysis, MC (P<0.000003) retained the most important influence on nodal metastasis. The overall survival analysis calculated by the Kaplan-Meier method revealed that tumours with high MC ( > 25 vessels/field) were significantly associated with increased death risk (log-rank test P = 0.00067; Cox's test P = 0.00046; Gehan's Wilcoxon test P = 0.00108). In 94 patients, the development of metastatic disease during follow-up was significantly related to MC. Indeed, patients who developed metastasis during follow-up showed a higher MC, either as a dichotomous (P = 0.01) or as a continuous (P = 0.003) variable, than patients who had developed no metastasis at the time of the analysis. Moreover, in the stepwise logistic regression analysis, MC retained the most important influence on distant metastases.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.Clin Cancer Res. 1997 Dec;3(12 Pt 1):2485-92. Clin Cancer Res. 1997. PMID: 9815651
-
Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence.Cancer. 1996 Aug 1;78(3):409-15. doi: 10.1002/(SICI)1097-0142(19960801)78:3<409::AID-CNCR5>3.0.CO;2-E. Cancer. 1996. PMID: 8697384
-
Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma.Mod Pathol. 1996 Jun;9(6):636-41. Mod Pathol. 1996. PMID: 8782200
-
Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.Lung Cancer. 2006 Feb;51(2):143-58. doi: 10.1016/j.lungcan.2005.09.005. Epub 2005 Dec 19. Lung Cancer. 2006. PMID: 16360975 Review.
-
The significance of intrapulmonary metastasis in non-small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system.Eur J Cardiothorac Surg. 2008 Aug;34(2):438-43; discussion 443. doi: 10.1016/j.ejcts.2008.03.070. Epub 2008 May 27. Eur J Cardiothorac Surg. 2008. PMID: 18502660 Review.
Cited by
-
Peripheral pulmonary nodules: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression.BMC Cancer. 2008 Jun 30;8:186. doi: 10.1186/1471-2407-8-186. BMC Cancer. 2008. PMID: 18590539 Free PMC article.
-
Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation.Clin Exp Metastasis. 1998 Oct;16(7):665-72. doi: 10.1023/a:1006554512338. Clin Exp Metastasis. 1998. PMID: 9932613
-
Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography.Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):22-8. doi: 10.1007/s00259-005-1932-7. Epub 2005 Sep 23. Eur J Nucl Med Mol Imaging. 2006. PMID: 16180030 Clinical Trial.
-
Intra-tumoural microvessel density in human solid tumours.Br J Cancer. 2002 May 20;86(10):1566-77. doi: 10.1038/sj.bjc.6600315. Br J Cancer. 2002. PMID: 12085206 Free PMC article. Review.
-
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis.Br J Cancer. 2002 Sep 23;87(7):694-701. doi: 10.1038/sj.bjc.6600551. Br J Cancer. 2002. PMID: 12232748 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical